Lyophilization of pertussis vaccine for use as a reference standard
Rodríguez, R.L.; Castillejos, R.; Ruiz Puente, J.; González Pacheco, M.
Salud Publica de Mexico 23(6): 603-606
1981
ISSN/ISBN: 0036-3634 PMID: 6801783 Document Number: 177996
Document emailed within 1 workday
Related Documents
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Tokunaga, H.; Kimura, T.; Kawamura, J. 1979: The National Institute of Hygieneic Sciences Reference Standard (The Japanese Pharmacopoeia Standard) "Deslanoside Reference Standard" Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 1979(97): 113-114
Wang, N.; Xiao, P.; Tian, G.; Jiang, H.; Piao, D.; Zhao, H.; Sun, Y. 2014: Comparison between the vaccine and the standard reference strains of Brucella Zhonghua Liu Xing Bing Xue Za Zhi 35(5): 613-614
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Ohta, M. 1980: On the National Institute of Hygienic Sciences standard (the Japanese Pharmacopoeia standard) "Reserpine Reference Standard (control 761)" Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 98: 132-133
Tokunaga, H.; Kimura, T.; Kawamura, J. 1973: On the National Institute of Hygienic Sciences Standard (the Japanese Pharmacopoeia Standard) "G-Strophanthin Reference Standard" Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 91(0): 63-64
Ohta, M.; Kimura, T.; Kawamura, J. 1980: On the National Institute of Hygienic Sciences standard (Japanese Pharmacopoeia standard) "Cortisone Acetate Reference Standard (control 741)" Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 98: 125-131
Mortimer, E.A. 1990: Pertussis and pertussis vaccine: 1990 Advances in Pediatric Infectious Diseases 5: 1-33
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Kijima, K.; Kawamura, J. 1972: On the National Institute of Hygienic Sciences standards (the Japanese pharmacopoeia standards), "hydrocortisone acetate reference standard" and "prednisolone acetate reference standard" Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 90: 92-93
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Todorova, R. 1973: Lyophilization of viruses and viral vaccines. III. Protective media for the lyophilization of the Komarov and la Soto strains of the Newcastle virus Veterinarno-Meditsinski Nauki 10(5): 49-53